72 related articles for article (PubMed ID: 1384709)
1. Development of a procedure for coupling the homing device glu-plasminogen to liposomes.
Heeremans JL; Kraaijenga JJ; Los P; Kluft C; Crommelin DJ
Biochim Biophys Acta; 1992 Oct; 1117(3):258-64. PubMed ID: 1384709
[TBL] [Abstract][Full Text] [Related]
2. Comparative studies of the preparation of immunoliposomes with the use of two bifunctional coupling agents and investigation of in vitro immunoliposome-target cell binding by cytofluorometry and electron microscopy.
Schwendener RA; Trüb T; Schott H; Langhals H; Barth RF; Groscurth P; Hengartner H
Biochim Biophys Acta; 1990 Jul; 1026(1):69-79. PubMed ID: 2378882
[TBL] [Abstract][Full Text] [Related]
3. Coupling of metal containing homing devices to liposomes via a maleimide linker: use of TCEP to stabilize thiol-groups without scavenging metals.
Visser CC; Voorwinden LH; Harders LR; Eloualid M; van Bloois L; Crommelin DJ; Danhof M; de Boer AG
J Drug Target; 2004; 12(9-10):569-73. PubMed ID: 15621682
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of conjugates of (modified) human serum albumin and liposomes: drug carriers with an intrinsic anti-HIV activity.
Kamps JA; Swart PJ; Morselt HW; Pauwels R; De Béthune MP; De Clercq E; Meijer DK; Scherphof GL
Biochim Biophys Acta; 1996 Jan; 1278(2):183-90. PubMed ID: 8593275
[TBL] [Abstract][Full Text] [Related]
5. Fibrin binding of plasminogen coated liposomes in vitro.
Heeremans JL; Los P; Prevost R; Crommelin DJ; Kluft C
Thromb Haemost; 1996 Jan; 75(1):134-9. PubMed ID: 8713792
[TBL] [Abstract][Full Text] [Related]
6. Use of liposomes to deliver bactericides to bacterial biofilms.
Jones MN
Methods Enzymol; 2005; 391():211-28. PubMed ID: 15721384
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of short polyoxyethylene-based heterobifunctional cross-linking reagents. Application to the coupling of peptides to liposomes.
Frisch B; Boeckler C; Schuber F
Bioconjug Chem; 1996; 7(2):180-6. PubMed ID: 8983339
[TBL] [Abstract][Full Text] [Related]
8. Thiolation of preformed liposomes with iminothiolane.
Lasch J; Niedermann G; Bogdanov AA; Torchilin VP
FEBS Lett; 1987 Apr; 214(1):13-6. PubMed ID: 3569510
[TBL] [Abstract][Full Text] [Related]
9. Immunoliposomes as enzyme-carriers (immuno-enzymosomes) for antibody-directed enzyme prodrug therapy (ADEPT): optimization of prodrug activating capacity.
Vingerhoeds MH; Haisma HJ; Belliot SO; Smit RH; Crommelin DJ; Storm G
Pharm Res; 1996 Apr; 13(4):604-10. PubMed ID: 8710754
[TBL] [Abstract][Full Text] [Related]
10. Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times.
Blume G; Cevc G; Crommelin MD; Bakker-Woudenberg IA; Kluft C; Storm G
Biochim Biophys Acta; 1993 Jun; 1149(1):180-4. PubMed ID: 8318529
[TBL] [Abstract][Full Text] [Related]
11. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent.
Carlsson J; Drevin H; Axén R
Biochem J; 1978 Sep; 173(3):723-37. PubMed ID: 708370
[TBL] [Abstract][Full Text] [Related]
12. Effect of covalent attachment of immunoglobulin fragments on liposomal integrity.
Bredehorst R; Ligler FS; Kusterbeck AW; Chang EL; Gaber BP; Vogel CW
Biochemistry; 1986 Sep; 25(19):5693-8. PubMed ID: 3778879
[TBL] [Abstract][Full Text] [Related]
13. [Features of the interaction of Glu- and Lys-forms of plasminogen with native and partially hydrolyzed fibrin].
Grinenko TV; Skomorovskaia EV; Kudinov SA; Zolotareva EN
Biokhimiia; 1992 May; 57(5):728-37. PubMed ID: 1322196
[TBL] [Abstract][Full Text] [Related]
14. Covalent modification of serum transferrin with phospholipid and incorporation into liposomal membranes.
Afzelius P; Demant EJ; Hansen GH; Jensen PB
Biochim Biophys Acta; 1989 Feb; 979(2):231-8. PubMed ID: 2647146
[TBL] [Abstract][Full Text] [Related]
15. Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting.
Martin FJ; Papahadjopoulos D
J Biol Chem; 1982 Jan; 257(1):286-8. PubMed ID: 7053372
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
17. Modification of liposomes with proteins by dansyl-labeled heterobifunctional crosslinker.
Chen T; Wang R; Lu T; Liang G; Lu T
J Biomater Appl; 2011 Jul; 26(1):117-25. PubMed ID: 20237178
[TBL] [Abstract][Full Text] [Related]
18. Signal-enhancing thermosensitive liposomes for highly sensitive immunosensor development.
Genç R; Murphy D; Fragoso A; Ortiz M; O'Sullivan CK
Anal Chem; 2011 Jan; 83(2):563-70. PubMed ID: 21155541
[TBL] [Abstract][Full Text] [Related]
19. Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Dos Santos N; Allen C; Doppen AM; Anantha M; Cox KA; Gallagher RC; Karlsson G; Edwards K; Kenner G; Samuels L; Webb MS; Bally MB
Biochim Biophys Acta; 2007 Jun; 1768(6):1367-77. PubMed ID: 17400180
[TBL] [Abstract][Full Text] [Related]
20. Lectin-mediated targeting of liposomes to a model surface. An ELISA method.
Hutchinson FJ; Jones MN
FEBS Lett; 1988 Jul; 234(2):493-6. PubMed ID: 2455661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
